Patents
Patents for C07D 405 - Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom (69,397)
01/2015
01/28/2015CN102459216B 肾外髓质钾通道的抑制剂 Inhibitors renal medulla potassium channels
01/28/2015CN101970428B 羧酰胺化合物及它们作为钙蛋白酶抑制剂的用途 Carboxamide compounds and their use as calpain inhibitor
01/28/2015CN101547905B 抗菌的喹啉衍生物 Antibacterial quinoline derivatives
01/27/2015US8940911 Squarylated lactones inhibitors for bacterial biofilm formation
01/27/2015US8940908 Method for preparing tetrazole methanesulfonic acid salts, and novel compound used in same
01/27/2015US8940776 2-acylaminopropoanol-type glucosylceramide synthase inhibitors
01/27/2015US8940773 Prolyl hydroxylase inhibitors and methods of use
01/27/2015US8940765 N-linked quinolineamide M1 receptor positive allosteric modulators
01/27/2015US8940745 Modulators of fatty acid amide hydrolase
01/27/2015US8940744 Pyrazolopyrimidine compounds as kinase inhibitors
01/27/2015US8940742 Heterocyclic compounds and uses thereof
01/27/2015US8940730 Methods and compositions of treating a Flaviviridae family viral infection
01/27/2015US8940726 PRMT5 inhibitors and uses thereof
01/27/2015US8940688 Fluorinated tripeptide HCV serine protease inhibitors
01/27/2015CA2766104C Heterocyclic sulfonamides, uses and pharmaceutical compositions thereof
01/27/2015CA2652834C Substituted arylimidazolones and -triazolones and the use thereof
01/23/2015CA2856505A1 New pyrrole derivatives, their preparation process and the pharmaceutical compounds containing them
01/22/2015WO2015009611A1 Inhibitors of leukotriene production
01/22/2015WO2015009102A1 Organic light emitting compound and organic electroluminescent element using same
01/22/2015WO2015008872A1 Cyanotriazole compounds
01/22/2015WO2015008229A1 Autotaxin inhibitors
01/22/2015WO2015007613A1 O-alkyl triazolyl carbamates as inhibitors of fatty acid amide hydrolase (faah)
01/22/2015WO2015007519A1 Novel benzimidazolium compounds
01/22/2015WO2015007517A1 Novel tetra- and pentasubstituted benzimidazolium compounds
01/22/2015WO2015007206A1 Afatinib acid addition salts and crystal forms thereof, preparation method and pharmaceutical composition thereof
01/22/2015WO2015006893A1 Uses of sesquiterpene lactone compound and derivative thereof in preparation of drugs
01/22/2015US20150025114 Substituted 1h-indazol-1-ol analogs as inhibitors of beta catenin/tcf protein-protein interactions
01/22/2015US20150025095 Diaminopyrimidines And Uses Thereof
01/22/2015US20150025069 Tofa analogs useful in treating dermatological disorders or conditions
01/22/2015US20150025056 Substituted cyclic hydroxamates as inhibitors of matrix metalloproteinases
01/22/2015US20150025054 (hetero)aryl cyclopropylamine compounds as lsd1 inhibitors
01/22/2015US20150025046 Preparation and use of bicyclic himbacine derivatives as par-1 receptor antagonists
01/22/2015US20150025041 Antiviral therapies with phospholipase d inhibitors
01/22/2015US20150023990 Alkoxy substituted imidazoquinolines
01/22/2015US20150023913 Hepatitis C Virus Inhibitors
01/22/2015DE102014213038A1 Organische Verbindung, Licht emittierendes Element, Anzeigemodul, Beleuchtungsmodul, Licht emittierende Vorrichtung, Anzeigevorrichtung, Beleuchtungsvorrichtung und elektronisches Gerät Organic compound, the light emitting element, display module, lighting module, light emitting device, display device, illumination device and electronic device
01/21/2015EP2826776A1 Solid amorphous form of (R)-1(2,2-difluorobenzo(D)(1,3)dioxol-5-yl)-N-(1-(2,3-dihydroxypropyl)-6-fluoro-2-(1-hydroxy-2-methylpropan-2-yl)-1H-indol-5-yl)-cyclopropanecarboxamide
01/21/2015EP2826775A1 Organic light emitting diode materials
01/21/2015EP2826774A1 Intermediates for 6-substituted phenoxychroman carboxylic acid derivatives
01/21/2015EP2826772A1 Intermediates for the synthesis of oxygen-substituted 3-heteroaroylamino-propionic acid derivatives
01/21/2015EP2825528A1 Substituted pyrrolidine-2-carboxamides
01/21/2015CN104302647A 新型吡啶并嘧啶衍生物及其用途 Novel pyridine and pyrimidine derivatives and their use
01/21/2015CN104302640A 3,5-二氨基吡唑激酶抑制剂 3,5-diamino-pyrazol-kinase inhibitor
01/21/2015CN104302636A C型肝炎病毒抑制剂 Hepatitis C virus inhibitors
01/21/2015CN104302634A 用于抑制abl1、abl2和bcr-abl1的活性的苯甲酰胺衍生物 For inhibiting abl1, abl2 and bcr-abl1 activity benzamide derivatives
01/21/2015CN104302358A 3-芳基-5-取代的异喹啉-1-酮化合物和它们的治疗用途 3-aryl-5-substituted isoquinolin-1-one compounds and their therapeutic use
01/21/2015CN104292220A 有机发光二极管材料 The organic light-emitting diode material
01/21/2015CN104292219A 1-(苯并呋喃-5-基)-2-(1,2,4-三唑-1-基)酮肟杂环甲醚及其作为抗癌药的应用 1- (benzofuran-5-yl) -2- (1,2,4-triazol-1-yl) oxime ether heterocycles and their use as anticancer agents
01/21/2015CN104292218A 用于电子薄膜和器件的喹唑啉衍生的化合物 Quinazoline compounds used in film and electronic devices derived
01/21/2015CN104292171A 3-[4-二-(4-氟苯)甲基哌嗪基]-1,2,4-三氮唑-5-硫酮Schiff碱的合成方法及其应用 3- [4- two - (4-fluorophenyl) methyl-piperazinyl] Synthesis 1,2,4-triazole-5-thione Schiff base and its application
01/21/2015CN104292165A 含氟和氮杂环的烯烃类化合物及其制备方法和用途 Olefin compound and its preparation method and use of fluorinated and heterocyclic
01/21/2015CN104292163A 具有抗多种肿瘤活性的格尔德霉素类似物及其制备方法和应用 With a variety of anti-tumor activity of geldanamycin analogs and its preparation method and application
01/21/2015CN103249728B 新三唑化合物iii New triazole compounds iii
01/21/2015CN102816153B 一种合成ve烟酸酯的方法 A synthetic approach ve trinicotinate
01/21/2015CN102812003B 吡咯烷羧酸衍生物、药物组合物以及在代谢紊乱中作为g-蛋白偶联受体43(gpr43)激动剂使用的方法 Pyrrolidine carboxylic acid derivatives, pharmaceutical compositions and as a method of g- protein coupled receptor 43 (gpr43) agonists for use in metabolic disorders
01/21/2015CN102405211B 作为组织蛋白酶抑制剂的脯氨酸衍生物 Cathepsin inhibitors as proline derivative
01/21/2015CN101351524B 萘嵌苯衍生物在太阳能电池中作为光敏剂的用途 Perylene derivative as a photosensitizer in the solar cell use
01/20/2015US8937303 Organic electroluminescent device
01/20/2015US8937189 Tri-substituted 2-benzhydryl-5-benzylamino-tetrahydro-pyran-4-ol and 6-benzhydryl-4-benzylamino-tetrahydro-pyran-3-ol analogues, and novel 3,6-disubstituted pyran derivatives
01/20/2015US8937150 Anti-viral compounds
01/20/2015US8937094 Triazole compounds that modulate HSP90 activity
01/20/2015US8937093 Heterocyclic aspartyl protease inhibitors
01/20/2015US8937083 Pesticidal compositions and processes related thereto
01/20/2015US8937073 Disubstituted tetrahydrofuranyl compounds and their use as B1-receptor antagonists
01/15/2015WO2015006591A1 2,4- or 4,6-diaminopyrimidine compounds as idh2 mutants inhibitors for the treatment of cancer
01/15/2015WO2015006520A1 Ido inhibitors
01/15/2015WO2015006280A1 Fused piperidine amides as modulators of ion channels
01/15/2015WO2015005489A1 Heterocyclic compound
01/15/2015WO2015004075A1 Modified bet-protein-inhibiting dihydroquinoxalinones and dihydropyridopyrazinones
01/15/2015WO2015003658A1 Protein tyrosine kinase modulators and methods of use
01/15/2015WO2015003640A1 Therapeutically active compounds and their methods of use
01/15/2015US20150018560 Process for preparing cis-5-[1-(4-chlorophenyl)-methylene]-1-hydroxymethyl-2,2-dimethylcyclopentanol
01/15/2015US20150018547 Aromatic ring compound
01/15/2015US20150018542 2-arylbenzofuran-7-formamide compounds, preparation method and use thereof
01/15/2015US20150018401 Novel ep4 agonist
01/15/2015US20150018373 Heterocyclic compound
01/15/2015US20150018370 Process for the preparation of form III of Vilazodone hydrochloride
01/15/2015US20150018363 Benzimidazole derivatives as mch receptor antagonists
01/15/2015US20150018347 Spirocyclic compounds as modulators of chemokine receptor activity
01/15/2015US20150018335 Carbamate compounds and of making and using same
01/15/2015US20150018328 Therapeutically active compounds and their methods of use
01/15/2015US20150018321 Derivatives of 1-phenyl-2-pyridinyl alkyl alcohols as phosphodiesterase inhibitors
01/15/2015US20150018315 Novel tetra- and pentasubstituted benzimidazolium compounds
01/15/2015US20150018314 Novel benzimidazolium compounds
01/15/2015US20150018310 Substituted 3-(5-membered unsaturated heterocyclyl-1, 3-dihydro-indol-2-one's and derivatives thereof as kinase inhibitors
01/15/2015US20150014656 Compound for organic optoelectronic device organic light emitting diode including the same and display including the organic light emitting diode
01/14/2015EP2824104A1 Process for the preparation of form III of Vilazodone hydrochloride
01/14/2015EP2822956A1 Mannose derivatives for treating bacterial infections
01/14/2015EP2822942A1 Benzodioxanes for inhibiting leukotriene production
01/14/2015EP2822941A1 Benzodioxanes in combination with other actives for inhibiting leukotriene production
01/14/2015EP2822940A1 Novel compounds for the treatment of dyslipidemia and related diseases
01/14/2015EP2822925A1 Cf3o-containing enaminoketones and their utilization for the preparation of cf3o-containing pyrazoles
01/14/2015EP2822656A1 3-aryl-5-substituted-isoquinolin-1-one compounds and their therapeutic use
01/14/2015CN104277032A 杀虫用芳基吡咯烷 Insecticidal aryl pyrrolidine
01/14/2015CN104276999A 3-羟基-5-芳基吡啶-2-甲酰胺衍生物的制备方法及中间体 3-hydroxy-5-aryl-2-carboxamide derivatives of preparation and intermediates
01/14/2015CN104276996A 化合物、有机发光二极管和显示装置 Compounds, and organic light emitting diode display device
01/14/2015CN103180305B 环氧基醇化合物的制造方法 Method for producing an epoxy group of an alcohol compound
01/14/2015CN102746281B 4-1,2,3-三氮唑-香豆素衍生物及其制备方法和用途 4-1,2,3- triazole - coumarin derivatives and their preparation and use
01/14/2015CN102659767B 一种光稳定剂及中间体4-环氧丙基-1,2,2,6,6-五甲基哌啶的制备方法 A light stabilizer and Intermediate Production Method 4 - epoxypropyl-1,2,2,6,6-pentamethyl-piperidine
01/14/2015CN101312948B 用于治疗炎症的lta4h的二芳基取代杂环抑制剂 Diaryl for treating inflammation lta4h substituted heterocyclic inhibitors
1 2 3 4 5 6 7 8 9 10 11 12 13 14 ... 694